指南与共识产科母胎医学

母胎医学会(SMFM)咨询系列第48号:为医学并发症高风险女性提供产后立即长效可逆避孕

Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
指南 / 共识 · Am J Obstet Gynecol · 2019-02-07

本咨询系列指出,有复杂健康问题或并发症高风险女性更需孕前规划与有效产后避孕;建议向未来妊娠不良事件风险最高的女性提供长效可逆避孕(LARC,GRADE 1B),产科人员在产前保健中讨论产后立即LARC并与女性共同决策,对考虑者告知取出率虽高于延迟放置但长期续用率更高、获益似超过风险(GRADE 1C)。

要点

  • 建议向未来妊娠不良事件风险最高的女性提供LARC(GRADE 1B)。
  • 产科人员应在产前保健中与所有孕妇讨论产后立即LARC,并参考美国避孕使用医学合格标准指南(GRADE 1C)。
  • 对希望且符合LARC指征者,推荐产后立即放置优于延迟放置(GRADE 1B)。

核心结论

  • 对有复杂健康状况或并发症高风险女性,提供包括产后立即LARC在内的避孕咨询与完整避孕选择是克服避孕障碍的手段。

研究设计与样本

  • 本文为母胎医学会(SMFM)咨询系列第48号,以教育所有提供者并倡导广泛实施产后立即LARC放置项目为目的。

主要发现

  • 医学复杂女性面临避孕使用障碍,包括复杂疾病风险增加女性保险不足等系统性障碍以及有效产后避孕使用率低。

关键数值与推荐

  • 推荐向未来妊娠不良事件风险最高的女性提供LARC(GRADE 1B)。
  • 推荐产科人员在产前保健中与所有孕妇讨论产后立即LARC的可及性,并查阅美国避孕使用医学合格标准指南以确定最适合特定医学状况的方法(GRADE 1C)。
  • 推荐对考虑产后立即宫内节育器放置的女性告知:虽然取出率高于延迟放置,但长期续用率更高,获益似超过取出风险(GRADE 1C)。
  • 推荐希望使用产后立即LARC的产科人员接受针对产后立即阶段的专门培训(BEST PRACTICE)。
  • 对希望且符合LARC指征的女性,推荐高风险妊娠后产后立即放置优于延迟放置,因总体有效性及成本效益更优(GRADE 1B)。

临床怎么用

  • 产科人员应在产前保健中与所有孕妇讨论产后立即LARC,并参考美国避孕使用医学合格标准指南选择适合特定医学状况的方法(GRADE 1C)。
  • 对希望且符合LARC指征者,推荐高风险妊娠后产后立即放置而非延迟放置(GRADE 1B)。
  • 对考虑产后立即宫内节育器放置者,应告知取出率高于延迟放置但长期续用率更高、获益似超过取出风险(GRADE 1C)。
  • 希望使用产后立即LARC的产科人员应接受针对产后立即阶段的专门培训(BEST PRACTICE)。
  • 避孕咨询项目应以患者为中心并在共享决策框架内提供以避免胁迫(BEST PRACTICE)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Reproductive planning is essential for all women and most important for those with complex health conditions or at high risk for complications. Pregnancy planning can allow these high-risk women the opportunity to receive preconception counseling, medication adjustment, and risk assessment related to health conditions that have a direct impact on maternal morbidity and mortality risk. Despite the need for pregnancy planning, medically complex women face barriers to contraceptive use, including systemic barriers, such as underinsurance for women at increased risk for complex medical conditions as well as low uptake of effective postpartum contraception. Providing contraceptive counseling and a full range of contraceptive options, including immediate postpartum long-acting reversible contraception (LARC), is a means of overcoming these barriers. The purpose of this document is to educate all providers, including maternal-fetal medicine subspecialists, about the benefits of postpartum contraception, and to advocate for widespread implementation of immediate postpartum LARC placement programs. The following are Society for Maternal-Fetal Medicine recommendations: we recommend that LARC be offered to women at highest risk for adverse health events as a result of a future pregnancy (GRADE 1B); we recommend that obstetric care providers discuss the availability of immediate postpartum LARC with all pregnant women during prenatal care and consult the U.S. Medical Eligibility Criteria for Contraceptive Use guidelines to determine methods most appropriate for specific medical conditions (GRADE 1C); we recommend that women considering immediate postpartum intrauterine device insertion be counseled that although expulsion rates are higher than with delayed insertion, the benefits appear to outweigh the risk of expulsion, as the long-term continuation rates are higher (GRADE 1C); we recommend that obstetric care providers wishing to utilize immediate postpartum LARC obtain training specific to the immediate postpartum period (BEST PRACTICE); for women who desire and are eligible for LARC, we recommend immediate postpartum placement after a high-risk pregnancy over delayed placement due to overall superior efficacy and cost-effectiveness (GRADE 1B); we recommend that women considering immediate postpartum LARC be encouraged to breastfeed, as current evidence suggests that these methods do not negatively influence lactation (GRADE 1B); for women who desire and are eligible for LARC, we suggest that early postpartum LARC placement be considered when immediate postpartum LARC placement is not feasible (GRADE 2C); and we recommend that contraceptive counseling programs be patient-centered and provided in a shared decision-making framework to avoid coercion (BEST PRACTICE).

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vricella LK, Gawron LM, Louis JM, et al. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications. Am J Obstet Gynecol. 2019. PMID: 30738885. doi:10.1016/j.ajog.2019.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。